Form 4: BioLife Solutions Executive Sells 4,000 Shares Under 10b5-1 Trading Plan
SEC Form 4
Sarah Aebersold, Chief Human Resources Officer of BioLife Solutions, sold 4,000 shares of common stock on April 1, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On April 1, 2024, Sarah Aebersold, the Chief Human Resources Officer of BioLife Solutions Inc. (BLFS), sold 4,000 shares of the company's common stock.
- The sale was executed at a price of $17.65 per share.
- The transaction was conducted under a Rule 10b5-1(c) trading plan adopted on December 15, 2023.
- Following the transaction, Aebersold directly owns 65,843 shares of BioLife Solutions.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing related to an insider stock sale under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure of insider trading activity. It's common for executives to use 10b5-1 trading plans to sell shares over time to avoid accusations of trading on inside information.
Stakeholder Impact
- The stock sale by an executive could have a minor impact on shareholder sentiment, but is unlikely to have a significant impact due to the pre-planned nature of the sale.
Key Dates
| Date | Description |
|---|---|
| 12/15/2023 | Date of adoption of Rule 10b5-1(c) trading plan |
| 04/01/2024 | Date of transaction (stock sale) |
| 04/03/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.